Stryker’s Robert Cohen said the next frontier in orthopedic care is connected technologies and personalized care.
The Numbers
Selected comments from the leaders of top orthopedic companies as they reported first quarter 2026 earnings.
Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.
Orthoflash®
This marks the company’s entry into the U.S. bone graft substitute market, and represents the first clearance of a device based on its proprietary JAZBI biomaterial.
June 19, 2026
,
HyperPlate fixation technology advances the SpeedPlate implant platform by incorporating FastPitch locking screws into the titanium compression implants.
June 18, 2026
,
Acquisition of the system, indicated for supplemental fusion of the non-cervical spine, is complete and U.S. launch has commenced.
June 18, 2026
,
The study evaluates VCFix used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform.
June 18, 2026
,
The company plans to expand the availability of the Versalock system to additional regions across the United States.
June 16, 2026
,
Competitive Landscape
ORTHOWORLD Experts talk you through market forecasts, company sales and key trends.
Industry Voices
